Review: Deoxyglucose compounds labeled with isotopes different from 18-fuoride: Is there a future in clinical practice?

Cancer Biotherapy and Radiopharmaceuticals

Volumn 23, Issue 3, 2008, Pages 376-381

  Xiong, Qing Feng ^a   Chen, Yue ^a  

^a SOUTHWEST MEDICAL UNIVERSITY   (China)

Author keywords

Deoxyglucose derivatives; Fluorine 18; Radiolabeling; Rhenium 188; Technetium 99m

Indexed keywords

CARBON 11; DEOXYGLUCOSE; ETHYLENEDICYSTEINEGLUCOSAMINE TC 99M; FLUORINE 18; FLUORODEOXYGLUCOSE; FLUORODEOXYGLUCOSE F 18; GALLIUM 68; MERTIATIDE TC 99M; METHYLGLUCOSIDE; N (2' HYDROXYBENZYL) 2 AMINO 2 DEOXY DEXTRO GLUCOSE; PENTETATE TECHNETIUM TC 99M; PENTETIC ACID; RADIOISOTOPE; RHENIUM 188; TECHNETIUM 99M;

CLINICAL PRACTICE; DRUG STRUCTURE; DRUG SYNTHESIS; ISOTOPE LABELING; KIDNEY TUBULE; MOLECULAR IMAGING; NEOPLASM; PRIORITY JOURNAL; REVIEW;

ANIMALS; DEOXYGLUCOSE; DIAGNOSTIC IMAGING; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; MICE; NEOPLASM TRANSPLANTATION; NEOPLASMS; PENTETIC ACID; POSITRON-EMISSION TOMOGRAPHY; RADIOISOTOPES; RHENIUM; TECHNETIUM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 46449123598     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2007.0443     Document Type: Review

References (38)

1. Gillies RJ, Gatenby RA. Why do cancers have high aerobic glycolysis? Nat Rev Cancer 2004;4:891.
2. 18F]fluorodeoxyglucose positron emission tomography. Eur J Nucl Med Mol Imaging 2006;33:683.
3. Tian M, Zhang H, Nakasone Y, et al. Expression of Glut-1 and Glut-3 in untreated oral squamous cell carcinoma compared with FDG accumulation in a PET study. Eur J Nucl Med Mol Imaging 2004;31:5.
4. Doot RK, Dunnwald LK, Schubert EK, et al. Dynamic and static approaches to quantifying 18F-FDG uptake for measuring cancer response to therapy, including the effect of granulocyte CSF. J Nucl Med 2007;48:920.
5. 99mTc-ethylenedicysteineglucosamine. Cancer Biother Radiopharm 2004;19:443.
6. 99mTc]-DTPADG) as a potential imaging modality for tumor. Appl Radiat Isot 2006;64:342.
7. 99mTc-DTPA-deoxyglucose: An experimental study. Cancer Biother Radiopharm 2007;22:403.
8. 188Re-DTPA-DG in MCF-7 breast carcinoma and A549 pulmonary carcinoma cells. Cancer Biother Radiopharm 2007;22:543.
9. 188Re-DTPA-deoxyglucose in MCF-7 tumor-bearing mice. Cancer Biother Radiopharm 2007;22:400.
10. Maldonado A, González-Alenda FJ, Alonso M, et al. PET-CT in clinical oncology. Clin Transl Oncol 2007;9:494.
11. Gillham C, Reynolds J, Hollywood D. Predicting the response of localised oesophageal cancer to neo-adjuvant chemoradiation. World J Surg Oncol 2007;5:97.
12. Oehr P, Ruhlmann J, Biersack HJ. FDG-PET in clinical oncology: review of the literature and report of one institution's experience. J Investig Med 1999;47:4521.
13. Yamamoto T, Seino Y, Fukumoto H, et al. Over-expression of facilitative glucose transporter genes in human cancer. Biochem Biophys Res Commun 1990;170:223.
14. Lindholm P, Minn H, Leskinen-Kallio S, et al. Influence of the blood glucose concentration on FDG uptake in cancer-a PET study. J Nucl Med 1993;34:1.
15. Brown RS, Leung JY, Fisher SJ, et al: Intratumoral distribution of tritiated-FDG in breast carcinoma: correlation between Glut-1 expression and FDG uptake. J Nucl Med 1996;37:1042.
16. Higashi T, Saga T, Nakamoto Y, et al: Relationship between retention index in dual-phase 18F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer. J Nucl Med 2002;43:173.
17. Brown RS, Goodman TM, Zasadny KR, et al. Expression of hexokinase II and Glut-1 in untreated human breast cancer. Nucl Med Biol 2002;29:443.
18. Mellanen P, Minn H, Grenman R, et al. Expression of glucose transporters in head-and-neck tumors. Int J Cancer 1994;56:622.
19. Buck AK, Schirrmeister H, Mattfeldt T, et al. Biological characterization of breast cancer by means of PET. Eur J Nucl Med Mol Imaging 2004;31:S80.
20. 18F]fluoro-2-deoxy-D-glucose in oncology. Part II. The clinical value in detecting and staging primary tumors. J Cancer Res Clin Oncol 2000;126:560.
21. 18F-fluorodeoxyglucose identifies tumor growth or thrombosis in the portal vein with hepatocellular carcinoma. World J Gastroenterol 2007;13:4529.
22. Maldonado A, González-Alenda FJ, Alonso M, et al. PET-CT in clinical oncology. Clin Transl Oncol 2007;9:494.
23. Yang DJ, Kim EE. Tracer development and hybrid imaging. Eur J Nucl Med Mol Imaging 2005;32:1001.
24. Ak I, Gulbas Z. Intense F-18 FDG accumulation in stomach in a patient with Hodgkin lymphoma: Helicobacter pylori infection as a pitfall in oncologic diagnosis with F-18 FDG PET imaging. Clin Nucl Med 2005;30:41.
25. 18F-FDG PET in primary staging of pulmonary malignancies. Eur J Nucl Med Mol Imaging 2005;32:641.
26. 99mTc-EC-DG targeted at the multifunctional glucose transport system: feasibility study with rodents. Radiology 2003;226:465.
27. Bryant J, Yang D, Schechter N, et al. Evaluation of Tc-99m-EC-DG in lung cancer patients. J Nucl Med 2007;48:354P.
28. Chen X, Li L, Liu F, et al. Synthesis and biological evaluation of technetium-99m-labeled deoxyglucose derivatives as imaging agents for tumor. Bioorg Med Chem Lett 2006;16:5503.
29. Rattat D, Schubiger PA, Berke HG, et al. Dicarbonylnitrosyl-complexes of rhenium (Re) and technetium (Tc), a potentially new class of compounds for the direct radiolabeling of biomolecules. Cancer Biother Radiopharm 2001;16:339.
30. 3]- core (M=Tc, Re) useful in radiopharmaceuticals: X-ray and NMR structural characterization and density functional calculations of species containing two sp3 N donors and one sp3 O donor. Inorg Chem 2004;43:7774.
31. Knapp FF Jr, Beets AL, Guhlke S, et al. Availability of rhenium-188 from the alumina-based tungsten-188/rhenium-188 generator for preparation of Rhenium-188-labeled radiopharmaceuticals for cancer treatment. Anticancer Res 1997;17:1783.
32. Seitz U, Neumaier B, Glatting G, et al. Preparation and evaluation of the rhenium-188-labeled anti-NCA antigen monoclonal antibody BW 250/183 for radioimmunotherapy of leukaemia. Eur J Nucl Med 1999;26:1265.
33. 188Re-direct labeling of monoclonal antibodies for radioiummunotherapy of solid tumors: biodistribution, normal organ dosimetry, and toxicology. Nucl Med Biol 1998;25:441.
34. 99mTc(I)- tricarbonyl complexes: a hint for the future functionalization of biomolecules. Bioconjug Chem 2000;11:345.
35. 186Re(I) tricarbonyl complexes of N-(2′-Hydroxybenzyl)-2-amino-2-deoxy-D-glucose. Bioconjug Chem 2004;15:923.
36. Ferreira CL, Ewart CB, Bayly SR, et al. Glucosamine conjugates of tricarbonylcyclopentadienyl rhenium(I) and technetium(I) Cores. Inorg Chem 2006;45:6979.
37. 11C-methyl-d-glucoside, a tracer of the sodium-dependent glucose transporters. J Nucl Med 2003;44:1082.
38. Win Z, Al-Nahhas A, Rubello D, et al. Somatostatin receptor PET imaging with Gallium-68 labeled peptides. Q J Nucl Med Mol Imaging 2007;51:244.